In the wake of the Food & Drug Administration’s (FDA) ambitious unified agenda, on July 13, 2026, the agency published a proposed rule aiming to align its regulatory frameworks with “how distributed manufacturing actually works.” The proposed rule would create a tailored drug establishment...
Two New Jersey men were sentenced this week for their roles in a drug trafficking organization that imported fentanyl analogues from China and distributed them in pill form throughout Northern New Jersey.Nine individuals have been charged and convicted for their roles in this drug trafficking...
Health Care Fraud Unit Secures Result in Landmark Case Targeting Executives of Fraudulent Mental Health Technology Company The founder and former Chief Executive Officer (CEO) Ruthia He of Done Global Inc., a California-based digital mental health company, was sentenced today to six...
Alibaba Group Holding Limited (Alibaba) — one of China’s largest companies — and its U.S.-based payment processor, AUS Merchant Services Inc. (AUS, and formerly known as Alipay US), have entered a non-prosecution agreement to pay $600 million to resolve the Justice Department’s allegations that...
WASHINGTON – Today, the U.S. Drug Enforcement Administration filed its intent to temporarily place 7-hydroxymitagynine (7-OH) and three related substances into Schedule I of the Controlled Substances Act (CSA). Prior to DEA issuing this notice, the Department of Health and Human Services (HHS...
The defendants earned more than $600,000 from the sales of illegally misbranded drugs, repackaging and selling them for the use of preventing aging; improving sexual performance; and increasing cognitive function BOSTON – A Massachusetts couple have been sentenced in federal court in Boston for...
The owner of two telemedicine companies was sentenced today to 120 months in prison and ordered to pay $66 million in restitution for her role in a scheme to fraudulently bill Medicare for medically unnecessary durable medical equipment and prescription drugs. According to court documents and...
The Drug Enforcement Administration exists to protect the American people. Fulfilling that mission requires not only aggressive action against the criminal organizations trafficking deadly drugs into our communities, but also accountability and public trust. Today, I requested that the U.S....
The Partnership for Safe Medicines today published a report outlining solutions to protect patients from the risks of a growing compounded GLP-1 marketplace. A Call to Action: Restoring and Strengthening America’s Patient Safety System serves as a detailed plan for policymakers and regulators to...
Providers in high-income countries underestimate the domestic scale of falsified medicine. Read Article #Counterfeit #PatientHarm
We Are a 501(c)(3)
Federal Tax ID: 52-1660752
DUNS Number: 073539913
1810 York Rd #435Lutherville, MD21093
Contactinfo@naddi.org
Corporate MembershipLearn MoreLogin/Join Us
Terms of UseCancellation/Refund PolicyCode of ConductCopyright PolicyPrivacy PolicyTrademark Policy